WHEN EXECUTIVES from Calando Pharmaceuticals met with the management team of Agilent Technologies' nucleic acid solutions division, the chemistry was obvious, says John Petrovich, Calando's chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback